Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonoscopy | 6 | 2021 | 524 | 1.450 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 1435 | 0.690 |
Why?
|
| Health Educators | 1 | 2017 | 8 | 0.600 |
Why?
|
| Video Recording | 1 | 2019 | 284 | 0.570 |
Why?
|
| Career Mobility | 1 | 2017 | 89 | 0.560 |
Why?
|
| Colorectal Neoplasms | 4 | 2021 | 3707 | 0.560 |
Why?
|
| Neurilemmoma | 1 | 2017 | 136 | 0.520 |
Why?
|
| Career Choice | 1 | 2017 | 212 | 0.520 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 166 | 0.500 |
Why?
|
| Gastroenterology | 1 | 2017 | 202 | 0.480 |
Why?
|
| Preoperative Care | 1 | 2019 | 1581 | 0.420 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 128 | 0.410 |
Why?
|
| Mass Screening | 4 | 2021 | 1547 | 0.400 |
Why?
|
| Amyloidosis | 1 | 2013 | 174 | 0.390 |
Why?
|
| Patient Compliance | 1 | 2016 | 678 | 0.380 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 147 | 0.370 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2015 | 481 | 0.360 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 964 | 0.350 |
Why?
|
| Intestine, Small | 1 | 2013 | 524 | 0.340 |
Why?
|
| Diarrhea | 2 | 2013 | 722 | 0.340 |
Why?
|
| Antidiarrheals | 1 | 2009 | 37 | 0.340 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 850 | 0.320 |
Why?
|
| Diabetes Complications | 1 | 2009 | 309 | 0.290 |
Why?
|
| Referral and Consultation | 1 | 2012 | 930 | 0.270 |
Why?
|
| Genetic Testing | 2 | 2015 | 1692 | 0.260 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 1344 | 0.260 |
Why?
|
| Algorithms | 3 | 2015 | 3906 | 0.250 |
Why?
|
| Celiac Disease | 2 | 2019 | 78 | 0.230 |
Why?
|
| Axonal Transport | 1 | 2003 | 39 | 0.220 |
Why?
|
| Histoplasma | 1 | 2013 | 36 | 0.210 |
Why?
|
| Histoplasmosis | 1 | 2013 | 78 | 0.210 |
Why?
|
| Colonic Diseases | 1 | 2013 | 72 | 0.200 |
Why?
|
| Histocytochemistry | 2 | 2017 | 194 | 0.190 |
Why?
|
| Occult Blood | 1 | 2021 | 63 | 0.190 |
Why?
|
| Wheat Hypersensitivity | 1 | 2019 | 3 | 0.170 |
Why?
|
| Cathartics | 1 | 2019 | 40 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1417 | 0.160 |
Why?
|
| Colon | 1 | 2013 | 684 | 0.160 |
Why?
|
| Diverticulitis | 1 | 2018 | 5 | 0.150 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 854 | 0.150 |
Why?
|
| Duodenal Diseases | 1 | 2018 | 48 | 0.150 |
Why?
|
| Dyspepsia | 1 | 2018 | 112 | 0.140 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 147 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 1581 | 0.130 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 94 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2018 | 377 | 0.120 |
Why?
|
| Humans | 16 | 2021 | 270601 | 0.120 |
Why?
|
| Middle Aged | 6 | 2021 | 90450 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 315 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 3435 | 0.100 |
Why?
|
| Medical Audit | 1 | 2012 | 194 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 224 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2013 | 342 | 0.090 |
Why?
|
| Loperamide | 1 | 2009 | 14 | 0.090 |
Why?
|
| Sweetening Agents | 1 | 2009 | 33 | 0.080 |
Why?
|
| Clonidine | 1 | 2009 | 67 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2012 | 637 | 0.080 |
Why?
|
| Octreotide | 1 | 2009 | 132 | 0.080 |
Why?
|
| Colitis | 1 | 2009 | 340 | 0.070 |
Why?
|
| Incidence | 2 | 2012 | 5825 | 0.070 |
Why?
|
| Metformin | 1 | 2009 | 397 | 0.060 |
Why?
|
| Male | 5 | 2019 | 128395 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 601 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 3190 | 0.060 |
Why?
|
| Decapodiformes | 1 | 2003 | 4 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 7919 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 1300 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 2343 | 0.060 |
Why?
|
| Huntingtin Protein | 1 | 2003 | 61 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 5923 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 140 | 0.050 |
Why?
|
| Guatemala | 1 | 2013 | 61 | 0.050 |
Why?
|
| Poisson Distribution | 1 | 2012 | 86 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2003 | 152 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 162 | 0.050 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 126 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 3395 | 0.050 |
Why?
|
| United States | 2 | 2012 | 15827 | 0.050 |
Why?
|
| Adult | 3 | 2019 | 81960 | 0.040 |
Why?
|
| Glutens | 1 | 2019 | 11 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 5 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2012 | 1562 | 0.040 |
Why?
|
| Female | 4 | 2019 | 148790 | 0.040 |
Why?
|
| Time Factors | 1 | 2012 | 12971 | 0.040 |
Why?
|
| Texas | 1 | 2009 | 6445 | 0.040 |
Why?
|
| Duodenoscopy | 1 | 2018 | 21 | 0.040 |
Why?
|
| SEER Program | 1 | 2012 | 1052 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 420 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 1503 | 0.040 |
Why?
|
| Duodenum | 1 | 2018 | 169 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5759 | 0.030 |
Why?
|
| Aged | 2 | 2017 | 73534 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 7787 | 0.030 |
Why?
|
| Risk Factors | 1 | 2009 | 17855 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 2656 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 5776 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 12527 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2009 | 33811 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 31084 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 61346 | 0.010 |
Why?
|